Table 2

Clinical characteristics
Characteristic Diabetes duration (yrs) Age (yrs) HbA1c (%) Patients with HbA1c <7.0%
n (%) Mean±SD n (%)
No. of patients 238,639 (100) 5.57±5.28 58.72±11.69 7.85±1.72 75,829 (31.78)
BMI
<24 kg/m2 110,283 (46.21) 5.44±5.26 58.43±11.73 7.85±1.79 36,507 (33.10)
≥24 kg/m2 128,356 (53.79) 5.67±5.29 58.98±11.66 7.86±1.67 39,322 (30.64)
P value <0.0001 <0.0001 0.2848 <0.0001
Treatment regimen
OAD only 157,212 (65.88) 4.76±4.65 58.16±11.52 7.67±1.58 54,438 (34.63)
1 OAD 58,028 (24.32) 4.38±4.95 57.45±12.08 7.65±1.69 21,834 (37.63)
2 OADs 80,113 (33.57) 4.74±4.34 58.35±11.21 7.66±1.53 26,942 (33.63)
≥3 OADs 19,071 (7.99) 6.01±4.71 59.56±10.89 7.75±1.49 5662 (29.69)
P value <0.0001 <0.0001 <0.0001 <0.0001
OAD + insulin 80,973 (33.93) 7.12±6.04 59.85±11.92 8.21±1.91 21,227 (26.21)
Prandial 6243 (2.62) 6.30±5.91 58.83±12.49 8.14±2.06 1745 (27.95)
Basal 13,816 (5.79) 6.58±5.54 59.13±11.97 7.99±1.81 4251 (30.77)
Premixes 53,122 (22.26) 7.20±6.02 60.24±11.66 8.18±1.86 13,787 (25.95)
Basal-bolus 6411 (2.69) 8.12±6.87 58.90±13.02 8.89±2.25 1143 (17.83)
Others 1381 (0.58) 8.70±6.75 60.70±12.57 8.45±2.00 301 (21.80)
P value <0.0001 <0.0001 <0.0001 <0.0001
OAD + GLP-1 RA 454 (0.19) 5.39±4.46 53.12±12.90 7.80±1.76 164 (36.12)
P valuea <0.0001 <0.0001 <0.0001 <0.0001
SMBG
Yes 90,557 (37.95) 5.86±5.25 58.96±11.46 7.68±1.62 31,979 (35.31)
No 148,082 (62.05) 5.39±5.29 58.58±11.83 7.96±1.77 43,850 (29.61)
P value <0.0001 <0.0001 <0.0001 <0.0001
Concomitant disease/complications
Yes 124,182 (52.04) 6.82±5.70 61.13±11.36 7.95±1.77 36,947 (29.75)
No 81,405 (34.11) 4.09±4.39 55.30±11.38 7.71±1.69 29,254 (35.94)
Don’t know 33,052 (13.85) 4.47±4.39 58.09±11.48 7.82±1.58 9,628 (29.13)
P value <0.0001 <0.0001 <0.0001 <0.0001

aComparison among different treatment regimens, ie, OAD only, OAD + insulin, OAD + GLP-1 RA.

P values were calculated using chi-square analysis and ANOVA as appropriate.

BMI, body mass index; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HbA1c, glycated hemoglobin; OAD, oral antidiabetes drug; SD, standard deviation; SMBG, self-monitored blood glucose.

Ji et al.

Ji et al. BMC Public Health 2013 13:602   doi:10.1186/1471-2458-13-602

Open Data